In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance

• Status: Suspended
• Trial end date: 2012-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Observational: studies in human beings in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: King Faisal University
• Treatments: Minocycline; Tigecycline

Criteria

Inclusion Criteria:

• All patients with infection with MDRs infections will be included

Exclusion Criteria:

• None